Transcriptomics

Dataset Information

0

CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy.

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE126072 | GEO | 2019/12/11

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [microarray]
2019-12-11 | GSE137016 | GEO
Transcriptomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [RNA-Seq]
2019-12-11 | GSE126071 | GEO
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq]
2019-12-11 | GSE126070 | GEO
Transcriptomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [scRNA-seq]
2019-12-11 | GSE137015 | GEO
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [ATAC-seq]
2019-12-11 | GSE137014 | GEO
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy.
| PRJNA520907 | ENA
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [microarray]
| PRJNA564284 | ENA
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [RNA-Seq]
| PRJNA520909 | ENA
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq]
| PRJNA520908 | ENA
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [ATAC-seq]
| PRJNA564279 | ENA